These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 37338707)

  • 1. Pharmacogenetic testing and counselling in the community pharmacy: mixed-methods study of a new pharmacist-led service.
    Jeiziner C; Meyer Zu Schwabedissen HE; Hersberger KE; Allemann SS
    Int J Clin Pharm; 2023 Dec; 45(6):1378-1386. PubMed ID: 37338707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patient perceptions of pharmacogenomic testing in the community pharmacy setting.
    Bright D; Worley M; Porter BL
    Res Social Adm Pharm; 2021 Apr; 17(4):744-749. PubMed ID: 32741696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mapping the implementation of pharmacogenomic testing in community pharmacies 2003-2021 using the Theoretical Domains Framework: A scoping review.
    Aref HAT; Makowsky MJ; Kung JY; Guirguis LM
    J Am Pharm Assoc (2003); 2023; 63(2):459-476.e6. PubMed ID: 36371398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Guide to a Pharmacist-Led Pharmacogenetic Testing and Counselling Service in an Interprofessional Healthcare Setting.
    Stäuble CK; Jeiziner C; Bollinger A; Wiss FM; Hatzinger M; Hersberger KE; Ihde T; Lampert ML; Mikoteit T; Meyer Zu Schwabedissen HE; Allemann SS
    Pharmacy (Basel); 2022 Jul; 10(4):. PubMed ID: 35893724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Independent Community Pharmacists' Experience in Offering Pharmacogenetic Testing.
    Haga SB; Mills R; Moaddeb J; Liu Y; Voora D
    Pharmgenomics Pers Med; 2021; 14():877-886. PubMed ID: 34290521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessing feasibility of delivering pharmacogenetic testing in a community pharmacy setting.
    Haga SB; Moaddeb J; Mills R; Voora D
    Pharmacogenomics; 2017 Mar; 18(4):327-335. PubMed ID: 28244804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patients' perspectives of a pharmacist-provided clinical pharmacogenomics service.
    Martin JL; Lee YM; Corbin LW; Colson R; Aquilante CL
    Pharmacogenomics; 2022 Jun; 23(8):463-474. PubMed ID: 35469451
    [No Abstract]   [Full Text] [Related]  

  • 8. Applications for pharmacogenomics in pharmacy practice: A scoping review.
    Hayashi M; Hamdy DA; Mahmoud SH
    Res Social Adm Pharm; 2022 Jul; 18(7):3094-3118. PubMed ID: 34474980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Community pharmacists' experience with pharmacogenetic testing.
    Moaddeb J; Mills R; Haga SB
    J Am Pharm Assoc (2003); 2015; 55(6):587-594. PubMed ID: 26409205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patient and healthcare professional acceptability of pharmacogenetic screening for DPYD and UGT1A1: A cross sectional survey.
    Glewis S; Krishnasamy M; Lingaratnam S; Harris S; Underhill C; Georgiou C; Warren M; Campbell R; IJzerman M; Fagery M; Campbell I; Martin JH; Tie J; Alexander M; Michael M
    Clin Transl Sci; 2023 Dec; 16(12):2700-2708. PubMed ID: 37877594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implementation of a pharmacist-led pharmacogenomics service for the Program of All-Inclusive Care for the Elderly (PHARM-GENOME-PACE).
    Bain KT; Schwartz EJ; Knowlton OV; Knowlton CH; Turgeon J
    J Am Pharm Assoc (2003); 2018; 58(3):281-289.e1. PubMed ID: 29602745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacists as Personalized Medicine Experts (PRIME): Experiences Implementing Pharmacist-Led Pharmacogenomic Testing in Primary Care Practices.
    Luke MJ; Krupetsky N; Liu H; Korenvain C; Crown N; Toenjes S; Sproule BA; Piquette-Miller M; Guirguis LM; McCarthy LM
    Pharmacy (Basel); 2021 Dec; 9(4):. PubMed ID: 34941633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of the clinical utility of pharmacogenetic guidance in a comprehensive medication management service.
    Rodríguez-Escudero I; Cedeño JA; Rodríguez-Nazario I; Reynaldo-Fernández G; Rodríguez-Vera L; Morales N; Jiménez-Vélez B; Ruaño G; Duconge J
    J Am Coll Clin Pharm; 2020 Sep; 3(6):1028-1037. PubMed ID: 32964197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Co-designing a community pharmacy pharmacogenomics testing service in the UK.
    Rendell T; Barnett J; Wright D
    BMC Health Serv Res; 2022 Mar; 22(1):378. PubMed ID: 35317803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of a pharmacogenetic educational toolkit for community pharmacists.
    Haga SB; Mills R; Moaddeb J
    Pharmacogenomics; 2016 Sep; 17(14):1491-502. PubMed ID: 27533631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Designing a theory and evidence informed pharmacogenomic testing service in community pharmacy in England.
    Rendell T; Barnett J; Scott S; Wright D
    Res Social Adm Pharm; 2022 Oct; 18(10):3831-3838. PubMed ID: 35428579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacist-Initiated Pre-Emptive Pharmacogenetic Panel Testing with Clinical Decision Support in Primary Care: Record of PGx Results and Real-World Impact.
    van der Wouden CH; Bank PCD; Özokcu K; Swen JJ; Guchelaar HJ
    Genes (Basel); 2019 May; 10(6):. PubMed ID: 31146504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implementation of a Pharmacogenomic Testing Service through Community Pharmacy in the Netherlands: Results from an Early Service Evaluation.
    Thornley T; Esquivel B; Wright DJ; Dop HVD; Kirkdale CL; Youssef E
    Pharmacy (Basel); 2021 Feb; 9(1):. PubMed ID: 33673111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Utility of Pharmacogenetic Testing and a Clinical Decision Support Tool to Enhance the Identification of Drug Therapy Problems Through Medication Therapy Management in Polypharmacy Patients.
    Kim K; Magness JW; Nelson R; Baron V; Brixner DI
    J Manag Care Spec Pharm; 2018 Dec; 24(12):1250-1259. PubMed ID: 30479202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nine-gene pharmacogenomics profile service: The Mayo Clinic experience.
    Matey ET; Ragan AK; Oyen LJ; Vitek CR; Aoudia SL; Ragab AK; Fee-Schroeder KC; Black JL; Moyer AM; Nicholson WT; Shrestha S; McAllister TM; Sinnwell JP; Faubion SS; Lazaridis KN
    Pharmacogenomics J; 2022 Feb; 22(1):69-74. PubMed ID: 34671112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.